这是一篇来自已证抗体库的有关
人类 CD84的综述,是根据7篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD84 抗体。
CD84 同义词: LY9B; SLAMF5; hCD84; mCD84; SLAM family member 5; CD84 antigen (leukocyte antigen); cell surface antigen MAX.3; hly9-beta; leucocyte differentiation antigen CD84; leukocyte antigen CD84; leukocyte differentiation antigen CD84; signaling lymphocytic activation molecule 5
BioLegend
小鼠 单克隆(CD84.1.21) | | BioLegend CD84抗体(BioLegend, CD84.1.21)被用于被用于流式细胞仪在人类样品上 (图 6a). Proc Natl Acad Sci U S A (2017) ncbi |
小鼠 单克隆(CD84.1.21) | | BioLegend CD84抗体(BioLegend, CD84.1.21)被用于被用于流式细胞仪在人类样品上 (图 1a). J Immunol (2017) ncbi |
小鼠 单克隆(CD84.1.21) | - 流式细胞仪; 小鼠; 图 e3a
- 流式细胞仪; 人类; 图 e6b
| BioLegend CD84抗体(Biolegend, CD84.1.21)被用于被用于流式细胞仪在小鼠样品上 (图 e3a) 和 被用于流式细胞仪在人类样品上 (图 e6b). Nature (2017) ncbi |
小鼠 单克隆(CD84.1.21) | | BioLegend CD84抗体(biolegend, CD84.1.21)被用于被用于流式细胞仪在人类样品上. Nature (2017) ncbi |
小鼠 单克隆(CD84.1.21) | | BioLegend CD84抗体(biolegend, CD84.1.21)被用于被用于流式细胞仪在人类样品上 (图 1d). Oncotarget (2016) ncbi |
小鼠 单克隆(CD84.1.21) | | BioLegend CD84抗体(Biolegen d, 326008)被用于被用于流式细胞仪在人类样品上 (图 st1). Exp Cell Res (2016) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(152-1D5) | | 圣克鲁斯生物技术 CD84抗体(Santa Cruz Biotechnology, sc-23899)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:150. J Cutan Pathol (2014) ncbi |
Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443
pubmed 出版商
Arumugakani G, Stephenson S, Newton D, Rawstron A, Emery P, Doody G,
et al. Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition. J Immunol. 2017;198:4618-4628
pubmed 出版商
Chen J, Zhong M, Guo H, Davidson D, Mishel S, Lu Y,
et al. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin. Nature. 2017;544:493-497
pubmed 出版商
Rao D, Gurish M, Marshall J, Slowikowski K, Fonseka C, Liu Y,
et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110-114
pubmed 出版商
Yigit B, Halibozek P, Chen S, O Keeffe M, Arnason J, Avigan D,
et al. A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells. Oncotarget. 2016;7:26346-60
pubmed 出版商
Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9
pubmed 出版商
Honarpisheh H, Glusac E, Ko C. Cytokeratin 20 expression in basaloid follicular hamartoma and infundibulocystic basal cell carcinoma. J Cutan Pathol. 2014;41:916-21
pubmed 出版商